#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Waldenstrom's macroglobulinaemia refractory Mantle cell lymphoma recurrent Narcolepsy Autologous haematopoietic stem cell transplant Trigeminal neuralgia Craniocerebral injury Cutaneous T-cell lymphoma stage I Andersen-Tawil syndrome Acute myeloid leukaemia recurrent Craniopharyngioma Squamous cell carcinoma of the hypopharynx Cytomegalovirus infection Lymphangiosarcoma Drug eruption Systemic scleroderma More trials…

    Learn about Rare Diseases

    Progressive supranuclear palsy – Diagnostics Isodicentric chromosome 15 syndrome – Life with Disease Myelodysplastic syndrome – Diagnostics Medulloblastoma recurrent – Life with Disease Marfan’s syndrome – Diagnostics Hereditary angioedema with C1 esterase inhibitor deficiency – Life with Disease Malignant fibrous histiocytoma – Life with Disease Langerhans’ cell histiocytosis – Life with Disease Ewing’s sarcoma recurrent Crigler-Najjar syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Palopegteriparatide Mycophenolate Mofetil CIRTUVIVINT Befiradol (18F) A24110He Sargramostim Methohexital Sodium Aficamten 4-Hydroxy-N-Desmethyltamoxifen Pyrimethamine Zalunfiban Galcanezumab Naporafenib Indocyanine Green Trametinib Cinnarizine XMAB942 Ads-011 Ibrexafungerp Vonafexor More therapies…

    Learn about Your Condition

    Cerebral palsy Schizophrenia Radiation skin injury Chronic hepatitis C Fallopian tube cancer stage IV Lymphangiosarcoma Inflammatory bowel disease Embolism Anxiety Paraganglion neoplasm Complicated appendicitis Hyperparathyroidism secondary Anal incontinence Thrombocytosis Takayasu's arteritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hypertension

  • Study on Sodium Zirconium Cyclosilicate for Patients with Chronic Kidney Disease Stages 3b and 4 to Allow More Fruits and Vegetables in Their Diet

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Sodium Zirconium Cyclosilicate
    The Netherlands
  • Study on Baxdrostat for Lowering Blood Pressure in Patients with Resistant Hypertension

    Not recruiting

    3 1
    Investigated Drugs:
    • Baxdrostat
    Belgium Bulgaria Czechia Germany Greece Hungary +3
  • Study on Lorundrostat for Patients with Uncontrolled and Resistant Hypertension

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hypertension
    Investigated Drugs:
    • Lorundrostat
    • Tetracosactide
    Bulgaria France Germany Italy The Netherlands Poland +2
  • Study on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Baxdrostat
    • Dapagliflozin
    Belgium Bulgaria Czechia Denmark France Germany +9
  • Study on the Effectiveness of Ethanol in Treating Hypertension in Patients with Uncontrolled High Blood Pressure

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hypertension
    Investigated Drugs:
    • Ethanol, Anhydrous
    Austria Belgium France Germany Ireland The Netherlands +1
  • Study on the Effects of Colchicine on Arterial Stiffness in Patients with High Blood Pressure

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Arterial stiffness
    • Hypertension
    Investigated Drugs:
    • Colchicine
    Denmark
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!